FDA Says to Drop Suicide Warning From GLP-1 Drug Labels

(MedPage Today) — The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the agency announced on Tuesday…

FDA calls on GLP-1 drugmakers to remove suicide warnings – Axios

FDA calls on GLP-1 drugmakers to remove suicide warnings  Axios US FDA requests removal of suicide warnings from weight-loss drugs  CNN US FDA requests removal of suicide warnings from weight-loss drug labels  Reuters FDA asks popular weight loss medication makers to remove suicide risk warning  kare11.com FDA Wants Suicide Warning Removed From Weight-Loss Drugs  Bloomberg.com

Giving up the booze

Americans are drinking less than ever—and a growing share are teetotalers. What’s behind the trend? What do the numbers show? That the U.S. is losing its taste for the hard stuff. In a recent Gallup survey, 54% of American adults said they consumed alcohol, the lowest level since the pollster began tracking drinking behavior in […]

Increased levels of Alzheimer’s-linked protein found in some with long COVID

A study of 227 individuals who experienced neurocognitive difficulties post COVID-19 infection—such as headaches, vertigo, balance dysregulation, changes in taste/smell, and brain fog—displayed a significant increase in their blood plasma of a crucial protein called tau, which is found in nerves and especially in the brain. Excess levels of tau are linked to neurodegenerative diseases […]

New combination therapy developed for frequent form of lung cancer

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of two well-studied classes of drugs—ERBB inhibitors and Aurora kinase inhibitors—is significantly more effective against KRAS-mutated lung adenocarcinomas than existing therapies. The research, currently […]

GLP-1s, tariffs and health: Why food brands are reformulating

Food reformulation is a a way to adapt to challenges, such as commodity price rises, regulations or tariffs. It is also a way to embrace opportunities, such as consumer demands for healthy options and the popularity of GLP-1 weight-loss drugs. How are brands reformulating?

Is Ozempic Really Making People Lose Their Hair?

Are GLP-1 drugs like Ozempic directly causing hair loss? A prolonged calorie deficit can disrupt our hair cycle and cause a temporary form of hair loss called telogen effluivum. — ULO HAIR GROWTH OFFERINGS (15% OFF, FOREVER): https://ulo.co/discount/perfecthairhealth15 Not sure where to start your hair regrowth journey? Take Ulo’s Treatment Recommendation Questionnaire: http://ulo.co/discount/perfecthairhealth15?redirect=#survey — WANT […]